{"schema_version":"secwatch.filing_event.v1","accession":"0001613103-25-000034","form_type":"8-K","ticker":"MDT","cik":"0001613103","company_name":"Medtronic plc","filed_at":"2025-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.191276+00:00","generated_at":"2026-05-24T15:40:31.481975+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Medtronic principal accounting officer Kirk resigns; Blomquist named successor","bullets":["Jennifer M. Kirk resigns as Global Controller & Principal Accounting Officer effective May 2, 2025 to become CEO of Exubrion Therapeutics.","Denise L. Blomquist, Assistant Global Controller, appointed as Global Controller & Principal Accounting Officer effective March 17, 2025.","Blomquist has 21-year Medtronic tenure; compensation aligns with similar officer positions under MIP, LTIP, and Change in Control Policy.","Kirk's departure not related to any disagreement over operations, policies, or practices; she will stay through May 2 for transition."],"urls":{"canonical":"https://secwatch.observer/filing/0001613103-25-000034","json":"https://secwatch.observer/filing/0001613103-25-000034.json","markdown":"https://secwatch.observer/filing/0001613103-25-000034.md","text":"https://secwatch.observer/filing/0001613103-25-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1613103/000161310325000034/0001613103-25-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1613103/000161310325000034/mdt-20250312.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T15:40:31.481975+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"764703993e","claim":"Jennifer M. Kirk resigned as Global Controller and Principal Accounting Officer at Medtronic plc.","evidence_excerpt":"On March 12, 2025, Jennifer M. Kirk, the Global Controller and Principal Accounting Officer of Medtronic plc (Company), notified the Company of her decision to resign from the Company, effective May 2, 2025, to become the chief executive officer of Exubrion Therapeutics, a privately held company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1613103/000161310325000034/0001613103-25-000034-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Global Controller and Principal Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"effd29eb8c","claim":"Denise L. Blomquist was appointed as Global Controller and Principal Accounting Officer at Medtronic plc.","evidence_excerpt":"The Company has appointed Denise L. Blomquist, currently the Company's Assistant Global Controller, to succeed Ms. Kirk as the Company's Global Controller and Principal Accounting Officer, effective March 17, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1613103/000161310325000034/0001613103-25-000034-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Global Controller and Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}